MRNX Stock: Earnings, Dividends & Analyst Estimates

Company Overview:

Market Cap: $5.91M

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $14.95 - $165.00

0.7 Year MRNX Performance Metrics:

Total Return (with DRIP): 560% (1,380.53% CAGR)

Total Return (no DRIP): 560% (1,380.53% CAGR)

Share Price: 560% (1,380.53% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $65,962

Total Return $ (with DRIP): $55,962

MRNX Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

MRNX Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for MRNX

Based on past 0.7-year performance, here are MRNX growth metrics:

Share price CAGR of +1380.53%
Dividend CAGR of +0%

Using MRNX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	MRNX (DRIP)	MRNX - No DRIP
Current Price	$134.43	$134.43
Start Shares	74.39	74.39
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	74.39	74.39
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$134.43	$134.43
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - MRNX

NOTE: Above numbers are our estimate based on MRNX's Dividend and Price CAGR over past 0.7 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Daily Target 2X Long MRNA ETF (MRNX) had its IPO on 2026-02-04, and is traded on AMEX stock exchange.

The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily return equivalent to 200% (twice) the daily percentage change in MRNA's stock price, which it maintains through daily rebalancing. However, holding the fund for periods exceeding a single day may lead to actual returns that deviate significantly from this 2x daily target, influenced by factors like market volatility, compounding, and rebalancing impacts. For collateral supporting its derivative contracts, MRNX may also invest in stable assets such as U.S. government securities, money market funds, short-term bond exchange-traded funds (ETFs), and investment-grade corporate debt.

MRNX website: https://www.defianceetfs.com/mrnx/